Adaptive Biotechnologies Announces Update to NCCN Guidelines® for Multiple Myeloma, Strengthening MRD Testing Recommendations and Specifically Referencing clonoSEQ®

Go back to Adaptive Biotechnologies Announces Update to NCCN Guidelines® for Multiple Myeloma, Strengthening MRD Testing Recommendations and Specifically Referencing clonoSEQ®
Steel Excel, Inc. (NASDAQ: ADPT) Delayed: 25.60 +1.18 (4.83%)
Previous Close $24.42    52 Week High $73.44 
Open $24.36    52 Week Low $7.91 
Day High $25.74    P/E N/A 
Day Low $24.25    EPS $0.00 
Volume 1,274,636